BNM-III-170 trifluoroacetate
Modify Date: 2024-01-16 14:54:35
BNM-III-170 trifluoroacetate structure
|
Common Name | BNM-III-170 trifluoroacetate | ||
|---|---|---|---|---|
| CAS Number | 1859189-55-1 | Molecular Weight | 674.958 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C25H26ClF7N6O6 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of BNM-III-170 trifluoroacetateBNM-III-170 TFA salt is a small-molecule CD4-mimetic compound that enhances vaccine efficacy against HIV-1 challenge in vivo; binds the HIV-1 gp120 Env and promotes conformational changes similar to those induced by CD4, exposing conserved Env elements to antibodies; synergizes with antibodies elicited by monomeric HIV-1 gp120 to protect monkeys from multiple high-dose intrarectal challenges with a heterologous simian-human immunodeficiency virus (SHIV). |
| Name | BNM-III-170 trifluoroacetate |
|---|
| Description | BNM-III-170 TFA salt is a small-molecule CD4-mimetic compound that enhances vaccine efficacy against HIV-1 challenge in vivo; binds the HIV-1 gp120 Env and promotes conformational changes similar to those induced by CD4, exposing conserved Env elements to antibodies; synergizes with antibodies elicited by monomeric HIV-1 gp120 to protect monkeys from multiple high-dose intrarectal challenges with a heterologous simian-human immunodeficiency virus (SHIV). |
|---|---|
| References | References 1. Madani N, et al. Nat Commun. 2018 Jun 18;9(1):2363. View Related Products by Target HIV |
| Molecular Formula | C25H26ClF7N6O6 |
|---|---|
| Molecular Weight | 674.958 |